Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Rheumatology | Musculoskeletal | Immunology | Family Medicine
 Disease Category: Rheumatoid Arthritis
Location: United States, MD

Trial Information

A randomized , double-blind, placebo-controlled , multicenter, two-part, dose ranging and confirmatory study with an operationally seamless design, evaluating efficacy and safety of IL-6Ra mAb on top of methotrexate in patients with active rheumatoid arthritis who are inadequate responders of MTX therapy.

Do you have Rheumatoid arthritis? You may qualify to participate in a clinical research study.

IL-6Ra mAb is a randomized placebo controlled trial of an injectable IL-6Rmab for patient with active rheumatoid arthritis on methotrexate with active joint disease. There is 22 weeks of randomization followed by 58 weeks of open label extension.

The Center for Rheumatology and Bone Research
2730 University Blvd West, Suite 306
Wheaton, MD 20902
Phone: 301 942-6610
Fax: 301 942-7833
Email: tbgoldman@arapc.com

View Map

Research Center Information: The Center for Rheumatology and Bone Research

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.